NEW YORK, Dec. 21, 2017 /PRNewswire/ -- WeissLaw LLP is
investigating possible breaches of fiduciary duty and other
violations of law by the Board of Directors of Kindred Healthcare
Inc. ("KND" or the "Company") (NYSE: KND) in connection with the
proposed acquisition of the Company by Humana Inc. ("HUM")
(NYSE: HUM) and two private equity firms. Under the
terms of the acquisition agreement, shareholders of KND will be
entitled to receive $9.00 in cash for
each KND share they own.
WeissLaw is investigating whether KND's Board acted to maximize
shareholder value prior to entering into the agreement.
Notably, at least one analyst set a target price of $11.00, or $2.00
above the offer price. Additionally, KND shares traded for
$11.90, or nearly $3.00 above the offer price, as recently as July
3.
Given these facts, WeissLaw is investigating whether KND
shareholders will obtain their fair and proportionate share of the
Company's continued success and future growth prospects. If
you own KND shares and would like more information about your
rights or our investigation, or if you have information to share
with us, please contact Joshua
Rubin by telephone at (888) 593-4771 or by
email at stockinfo@weisslawllp.com.
WeissLaw LLP has litigated hundreds of stockholder class and
derivative actions for violations of corporate and fiduciary
duties. We have recovered over a billion dollars for
defrauded clients and obtained important corporate governance
relief in many of these cases. If you have information or
would like legal advice concerning possible corporate wrongdoing
(including insider trading, waste of corporate assets, accounting
fraud, or materially misleading information), consumer fraud
(including false advertising, defective products, or other
deceptive business practices), or anti-trust violations, please
email us at stockinfo@weisslawllp.com or fill out the
form on our website,
http://www.weisslawllp.com/kindred-healthcare-inc/
View original
content:http://www.prnewswire.com/news-releases/weisslaw-llp-kindred-healthcare-inc-merger-may-not-be-in-the-best-interests-of-knd-shareholders-300574762.html
SOURCE WeissLaw LLP